Chi_Principles and Practice of Gynecologic Oncology 8e

xxii Contents

4.2

Genetics and Molecular Biology of Cervical Cancer 87 Dmitriy Zamarin Cervical Cancer: Clinical Presentation and Diagnostic Evaluation 88 Charles A. Leath III and Teresa K. L. Boitano Surgery for Cervical Cancer 93 Charles A. Leath III and Teresa K. L. Boitano Cervical Cancer: Pathology 97 Charles A. Leath III and Teresa K. L. Boitano Radiation Therapy, Immunotherapy, and Targeted Therapies in Cervix Cancer 105 Dmitriy Zamarin, Charles A. Kunos, Casey W. Williamson, Jyoti Mayadev, and Ramez N. Eskander Treatment of Persistent or Recurrent Uterine Cervix Cancer 115 Charles A. Leath III and Teresa K. L. Boitano Survivorship Issues Following Treatment for Cervical Cancer 117 Laura Salama and Don S. Dizon Cervical Cancer: Future Directions 119 Charles A. Leath III and Teresa K. L. Boitano Endometrial Cancer: Introduction, Anatomy, Natural History, and Patterns of Spread 123 Amy Bregar Endometrial Cancer: Etiology, Epidemiology, Risk Factors, Genetics, and Molecular Biology 127 Amy Bregar Endometrial Cancer: Clinical Presentation, Diagnostic Evaluation, and Workup 130 Amy Bregar Endometrial Cancer: Pathology and Prognostic Factors 148 Christine Chin Therapy for Endometrial Cancer: Radiation, Chemotherapy, Targeted, Immunotherapy, and Other New and Novel Agents 159 Susana M. Campos and Marcela G. del Carmen Treatment of Persistent and Recurrent Endometrial Cancer 180 Susana M. Campos Endometrial Cancer: Special Conditions 181 Allison Gockley Endometrial Cancer: Follow-Up and Survivorship Issues 183 Allison Gockley Endometrial Cancer: Future Directions 185 Allison Gockley Surgery for Endometrial Cancer 133 Christine Chin

SECTION 6 CORPUS: MESENCHYMAL TUMORS 187 6.1 Mesenchymal Tumors: Introduction, Anatomy, Natural History, and Patterns of Spread 189 Tiffany Y. Sia and Mario M. Leitao Jr Mesenchymal Tumors: Etiology, Epidemiology, and Risk Factors 191 Tiffany Y. Sia, Mario M. Leitao Jr, and Lora Hedrick Ellenson 6.2 Mesenchymal Tumors: Clinical Presentation and Diagnostic Evaluation and Workup 193 Tiffany Y. Sia and Mario M. Leitao Jr Surgery for Newly Diagnosed Uterine Corpus Mesenchymal Tumors 197 Tiffany Y. Sia and Mario M. Leitao Jr Pathology of Uterine Mesenchymal Tumors 202 Amir Momeni-Boroujeni and Lora Hedrick Ellenson 6.4 6.5 Radiation Therapy for Uterine Corpus Mesenchymal Tumors 213 Matthew M. Harkenrider Chemotherapy for Uterine-Limited and Advanced Uterine Sarcomas 216 Kathryn M. Miller and Roisin E. O’Cearbhaill Surgery for Persistent and Recurrent Uterine Sarcomas 231 Tiffany Y. Sia and Mario M. Leitao Jr Uterine Sarcomas: Follow-Up, Survivorship Issues, and Future Directions 232 Tiffany Y. Sia and Mario M. Leitao Jr SECTION 7 GESTATIONAL TROPHOBLASTIC DISEASE: MOLAR PREGNANCY AND GESTATIONAL TROPHOBLASTIC NEOPLASIA 235 7.1 Epidemiology, Genetics, and Pathology in Gestational Trophoblastic Disease 237 Sue Yazaki Sun, Gabriela Paiva, and Antonio Braga 6.7 6.8 6.9 Management of Molar Pregnancy 247 Kevin M. Elias, Neil S. Horowitz, and Ross S. Berkowitz Management of Low-Risk Gestational Trophoblastic Neoplasia 251 Neil S. Horowitz, Ross S. Berkowitz, and Kevin M. Elias Management of High-Risk Gestational Trophoblastic Neoplasia 257 Antonio Braga, Fernanda Freitas Oliveira Cardoso, and Izildinha Maestá Gestational Trophoblastic Disease: Postdiagnosis and Treatment, Long-Term Sequelae, and Quality-of-Life Issues 267 Neil S. Horowitz, Kevin M. Elias, and Ross S. Berkowitz 7.3 7.4 7.5 6.3 6.6 7.2

4.3

4.4

4.5

4.6

4.7

4.8

4.9

SECTION 5 CORPUS: EPITHELIAL TUMORS 121 5.1

5.2

5.3

5.4

5.5

5.6

5.7

Copyright © 2024 Wolters Kluwer, Inc. Unauthorized reproduction of the content is prohibited.

5.8

5.9

5.10